现代实用医学
現代實用醫學
현대실용의학
MODERN PRACTICAL MEDICINE
2009年
6期
564-566,569
,共4页
田进信%黄童%袁静义%丁小云%徐磊%厉有名
田進信%黃童%袁靜義%丁小雲%徐磊%厲有名
전진신%황동%원정의%정소운%서뢰%려유명
脂肪肝%代谢综合征%数据收集
脂肪肝%代謝綜閤徵%數據收集
지방간%대사종합정%수거수집
Fatty liver%Metabolic syndrome%Data collection
目的 调查中国镇海炼化公司的脂肪性肝病、代谢综合征的流行病学情况及其相互关系. 方法对镇海炼化公司体检人群9543人进行调查分析;获取一般资料,进行体格检查,获取生化指标,脂肪肝采用B超诊断,代谢综合征诊断根据2005年IDF标准. 结果9543人中脂肪性肝病1177例,患病率12.3%:代谢综合征1289例,患病率13.6%;根据性别分层发现,随着年龄增加,脂肪性肝病及代谢综合征患病率增高,趋势检验示有统计学意义(P<0.05);脂肪性肝病具有代谢综合征危险因素的聚集,而代谢综合征人群中脂肪性肝病的患病率也高于对照组(P<0.05). 结论镇海炼化公司脂肪性肝病和代谢综合征的患病率分别为12.3%和13.6%,脂肪性肝病具有代谢综合征危险因素的聚集.
目的 調查中國鎮海煉化公司的脂肪性肝病、代謝綜閤徵的流行病學情況及其相互關繫. 方法對鎮海煉化公司體檢人群9543人進行調查分析;穫取一般資料,進行體格檢查,穫取生化指標,脂肪肝採用B超診斷,代謝綜閤徵診斷根據2005年IDF標準. 結果9543人中脂肪性肝病1177例,患病率12.3%:代謝綜閤徵1289例,患病率13.6%;根據性彆分層髮現,隨著年齡增加,脂肪性肝病及代謝綜閤徵患病率增高,趨勢檢驗示有統計學意義(P<0.05);脂肪性肝病具有代謝綜閤徵危險因素的聚集,而代謝綜閤徵人群中脂肪性肝病的患病率也高于對照組(P<0.05). 結論鎮海煉化公司脂肪性肝病和代謝綜閤徵的患病率分彆為12.3%和13.6%,脂肪性肝病具有代謝綜閤徵危險因素的聚集.
목적 조사중국진해련화공사적지방성간병、대사종합정적류행병학정황급기상호관계. 방법대진해련화공사체검인군9543인진행조사분석;획취일반자료,진행체격검사,획취생화지표,지방간채용B초진단,대사종합정진단근거2005년IDF표준. 결과9543인중지방성간병1177례,환병솔12.3%:대사종합정1289례,환병솔13.6%;근거성별분층발현,수착년령증가,지방성간병급대사종합정환병솔증고,추세검험시유통계학의의(P<0.05);지방성간병구유대사종합정위험인소적취집,이대사종합정인군중지방성간병적환병솔야고우대조조(P<0.05). 결론진해련화공사지방성간병화대사종합정적환병솔분별위12.3%화13.6%,지방성간병구유대사종합정위험인소적취집.
Objective To investigate the epidemiology of fatty liver, metabolic syndrome, and their relat-iongship in Sinopec Zhenhai Refining& Chemical Company(ZRCC). Methods 9543 people for health exam-ination were chosen to observe their data of general imformation, physical examination, biochemical parameter. Fatty liver was diagnosed according to two dimension ultrasound. Metabolic syndrome was diagnosed according to 2005 IDF criteria. Results Of 9543 people, 1177 were diagnosed as fatty liver, and the prevalence of fatty live was 12.3%; 1289 were diagnosed as metabolic syndrome, and the prevalence of metabolic syndrome was 13.6%. The prevalence of both was increased with aging(P<0.05). The prevalence of fatty liver in people with metabolic syndrome was higher than that in the control group, and the prevalence of metabolic syndrome in people with fatty liver was also higher than that in the control group. Conclusion The prevalence of fatty liver and metabolic syndrome were 12.3% and 13.6% respectively in ZRCC. Fatty liver is the accumulation of risk factors of metabolic syndrome.